Impact of Comorbidities on the Long-Term Prognosis of Patients with Intermittent Claudication

1. Correction to: 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017 Mar 21;135(12):e791-e792. Erratum for: Circulation. 2017 Mar21;135(12):e726-e779. PMID: 28320816.10.1161/CIR.0000000000000502Search in Google Scholar

2. Erratum in: J Cardiopulm Rehabil Prev. 2018 Sep;38(5):347. Anand SS, Caron F, et al. DN. 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary. Vasc Med. 2017 Jun;22(3):NP1-NP43.Search in Google Scholar

3. Agrawal K, Eberhardt RT. Contemporary medical management of peripheral arterial disease: a focus on risk reduction and symptom relief for intermittent claudication. Cardiol Clin. 2015 Feb;33(1):111-37. doi: 10.1016/j.ccl.2014.09.010. PMID: 25439335.10.1016/j.ccl.2014.09.010Search in Google Scholar

4. Fiotti N, Altamura N, Cappelli C, Schillan M, Guarnieri G, Giansante C. Long term prognosis in patients with peripheral arterial disease treated with antiplatelet agents. Eur J Vasc Endovasc Surg. 2003 Oct;26(4):374-80. doi: 10.1016/s1078-5884(03)00318-6. PMID: 14511998.10.1016/S1078-5884(03)00318-6Search in Google Scholar

5. Lau JF, Weinberg MD, Olin JW. Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis. Nat Rev Cardiol. 2011 May 31;8(7):405-18. doi: 10.1038/nrcardio.2011.66. PMID: 21629211.10.1038/nrcardio.2011.6621629211Search in Google Scholar

6. Schramm K, Rochon PJ. Gender Differences in Peripheral Vascular Disease. Semin Intervent Radiol. 2018 Mar;35(1):9-16. doi: 10.1055/s-0038-1636515. Epub 2018 Apr 5. PMID:29628610; PMCID: PMC5886764.10.1055/s-0038-1636515588676429628610Search in Google Scholar

7. Teodorescu VJ, Vavra AK, Kibbe MR. Peripheral arterial disease in women. J Vasc Surg. 2013 Apr;57(4 Suppl):18S-26S. doi: 10.1016/j.jvs.2012.10.115. PMID: 23522713.10.1016/j.jvs.2012.10.11523522713Search in Google Scholar

8. Serrano Hernando FJ, Martín Conejero A. Enfermedad arterial periférica: aspectos fisiopatológicos, clínicos y terapéuticos [Peripheral artery disease: pathophysiology, diagnosis and treatment]. Rev Esp Cardiol. 2007 Sep;60(9):969-82. Spanish. doi: 10.1157/13109651. PMID: 17915154.10.1157/1310965117915154Search in Google Scholar

9. Swedish Council on Health Technology Assessment. Peripheral Arterial Disease - Diagnosis and Treatment: A Systematic Review [Internet]. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Nov. SBU Yellow Report No. 187. PMID: 28876730.Search in Google Scholar

10. Cronin O, Morris DR, Walker PJ, Golledge J. The association of obesity with cardiovascular events in patients with peripheral artery disease. Atherosclerosis. 2013 Jun;228(2):316-23. doi: 10.1016/j.atherosclerosis. 2013.03.002. Epub 2013 Mar 14. PMID: 23601238.10.1016/j.atherosclerosis.2013.03.002Search in Google Scholar

11. Agarwal AK, Singh M, Arya V, Garg U, Singh VP, Jain V. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors. J Assoc Physicians India. 2012 Jul;60:28-32. PMID: 23405538.Search in Google Scholar

12. Weerarathna TP, Herath M, Liyanage G, Weerarathna MK, Senadheera V. Prevalence and Associations of Subclinical Peripheral Artery Disease among Patients with Type 2 Diabetes without Clinical Macrovascular Disease. Int J Prev Med. 2019 Jun 7;10:106. doi: 10.4103/ijpvm. IJPVM_427_18. PMID: 31360353; PMCID: PMC6592105.10.4103/ijpvm.IJPVM_427_18Search in Google Scholar

13. Stein R, Hriljac I, Halperin JL, Gustavson SM, Teodorescu V, Olin JW. Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease. Vasc Med. 2006 Feb;11(1):29-33. doi: 10.1191/1358863x06vm663oa. PMID: 16669410.10.1191/1358863x06vm663oa16669410Search in Google Scholar

14. Miossec A, Tollenaere Q, Lanéelle D, Guilcher A, Métairie A, Le Pabic E, Carel A, Le Faucheur A, Mahé G. Arterial Doppler Waveforms Are Independently Associated With Maximal Walking Distance in Suspected Peripheral Artery Disease Patients. Front Cardiovasc Med. 2021 Apr 20;8:608008. doi: 10.3389/fcvm.2021.608008. PMID: 33959640; PMCID: PMC8093382.10.3389/fcvm.2021.608008809338233959640Search in Google Scholar

15. Singh TP, Morris DR, Smith S, Moxon JV, Golledge J. Systematic Review and Meta-Analysis of the Association Between C-Reactive Protein and Major Cardiovascular Events in Patients with Peripheral Artery Disease. Eur J Vasc Endovasc Surg. 2017 Aug;54(2):220-233. doi: 10.1016/j.ejvs.2017.05.009. Epub 2017 Jun 27. PMID: 28666785.10.1016/j.ejvs.2017.05.00928666785Search in Google Scholar

16. Tisi PV, Hulse M, Chulakadabba A, et al. Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg 1997;14(5):344–50.10.1016/S1078-5884(97)80283-3Search in Google Scholar

17. Rossi E, Biasucci LM, Citterio F, Pelliccioni S, Monaco C, Ginnetti F, Angiolillo DJ, Grieco G, Liuzzo G, Maseri A. Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of Creactive protein. Circulation. 2002 Feb 19;105(7):800-3. doi: 10.1161/hc0702.104126. PMID: 11854118.10.1161/hc0702.10412611854118Search in Google Scholar

18. Hardman RL, Jazaeri O, Yi J, Smith M, Gupta R. Overview of classification systems in peripheral artery disease. Semin Intervent Radiol. 2014;31(4):378-388. doi:10.1055/s-0034-139397610.1055/s-0034-1393976423243725435665Search in Google Scholar

19. Aronow WS. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease. Drugs Aging. 1999 Aug;15(2):91-101. doi: 10.2165/00002512-199915020-00003. PMID: 10495069.10.2165/00002512-199915020-0000310495069Search in Google Scholar